Cargando…
Safety and Efficacy of Adult Stem Cell Therapy for Acute Myocardial Infarction and Ischemic Heart Failure (SafeCell Heart): A Systematic Review and Meta‐Analysis
Preclinical and clinical evidence suggests that mesenchymal stem cells (MSCs) may be beneficial in treating both acute myocardial infarction (AMI) and ischemic heart failure (IHF). However, the safety profile and efficacy of MSC therapy is not well‐known. We conducted a systematic review of clinical...
Autores principales: | Lalu, Manoj M., Mazzarello, Sasha, Zlepnig, Jennifer, Dong, Yuan Yi (Ryan), Montroy, Joshua, McIntyre, Lauralyn, Devereaux, P.J., Stewart, Duncan J., David Mazer, C., Barron, Carly C., McIsaac, Daniel I., Fergusson, Dean A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6265630/ https://www.ncbi.nlm.nih.gov/pubmed/30255989 http://dx.doi.org/10.1002/sctm.18-0120 |
Ejemplares similares
-
Safety of Cell Therapy with Mesenchymal Stromal Cells (SafeCell): A Systematic Review and Meta-Analysis of Clinical Trials
por: Lalu, Manoj M., et al.
Publicado: (2012) -
Assessment of safety and efficacy of mesenchymal stromal cell therapy in preclinical models of acute myocardial infarction: a systematic review protocol
por: Barron, Carly C., et al.
Publicado: (2017) -
Regenerative cell therapy for pulmonary arterial hypertension in animal models: a systematic review
por: Suen, Colin M., et al.
Publicado: (2019) -
What about now?
por: McIntyre, Paul
Publicado: (2023) -
Efficacy and safety of regenerative cell therapy for pulmonary arterial hypertension in animal models: a preclinical systematic review protocol
por: Suen, Colin M., et al.
Publicado: (2016)